Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Solomon
    Solomon
  2. Jarnagin
    Jarnagin
  3. D'Angelica
    D'Angelica
  4. Kingham
    Kingham
  5. Gonen
    Gonen
  6. Yarmohammadi
    Yarmohammadi
  7. Jones
    Jones
  8. Sofocleous
    Sofocleous
  9. Erinjeri
    Erinjeri
  10. Molena
    Molena

Groups

  1. Sloan Kettering Institute Postdocs (495)
  2. Surgery (192)
  3. Department of Medicine (152)
  4. Center for Pancreatic Cancer Research (129)
  5. Radiology, Department of (128)
  6. GSK Faculty (124)
  7. Survivorship Research (104)
  8. Epidemiology and Biostatistics (100)
  9. Solid Tumor Oncology Division (90)
  10. Graduate Medical Education (88)
Search Within
  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (258)
  2. Meeting Abstract (195)
  3. Review (14)
  4. Correspondence (10)
  5. Research Letter (10)
  6. Editorial (7)
  7. Guidelines (1)
Groups
  1. Sloan Kettering Institute Postdocs (495)
  2. Surgery (192)
  3. Department of Medicine (152)
  4. Center for Pancreatic Cancer Research (129)
  5. Radiology, Department of (128)
  6. GSK Faculty (124)

More Groups

People
  1. Stephen Solomon (44)
  2. William Jarnagin (42)
  3. Salvador Rodriguez (40)
  4. Michael D'Angelica (39)
  5. T Peter Kingham (38)
  6. Elena Petre (33)

More People

Years
  1. 2025 (17)
  2. 2024 (47)
  3. 2023 (42)
  4. 2022 (44)
  5. 2021 (59)
  6. 2020 (49)

More Years

Publications
  1. Journal of Vascular and Interventional Radiology (77)
  2. Journal of Investigative Dermatology (75)
  3. Journal of the American College of Surgeons (60)
  4. European Urology (36)
  5. Journal of Molecular Diagnostics (34)
  6. Journal of Urology (22)

More Publications

Results (495)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Surveillance of sentinel node-positive melanoma patients with reasons for exclusion from MSLT-II: Multi-institutional propensity score matched analysis
    Journal Article

    Broman, K. K.; Hughes, T. M.; Dossett, L. A.; Sun, J.; Carr, M. J.; Kirichenko, D. A.; Sharma, A.; Bartlett, E. K.; Nijhuis, A. A.; Thompson, J. F.; more...
    Journal of the American College of Surgeons (2021)

    Fulltext@MSK | Save
  • American trends in oncoplastic breast surgery for 2006–2015: A retrospective analysis of NSQIP database
    Research Letter

    Panchal, H.; Shukla, D.; Razdan, S. N.; El-Tamer, M.; Matros, E.; Henderson, P. W.
    Journal of Plastic Reconstructive and Aesthetic Surgery (2021)

    Fulltext@MSK | Save
  • Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features
    Journal Article

    Zhu, C.; Ho, Y. J.; Salomao, M. A.; Dapito, D. H.; Bartolome, A.; Schwabe, R. F.; Lee, J. S.; Lowe, S. W.; Pajvani, U. B.
    Journal of Hepatology (2021)

    Fulltext@MSK | Save
  • Efficacy of PARP inhibition in metastatic castration-resistant prostate cancer is very different with non-BRCA DNA repair alterations: Reconstructing prespecified endpoints for cohort B from the phase 3 PROfound trial of olaparib
    Research Letter

    Stopsack, K. H.
    European Urology (2021)

    Fulltext@MSK | Save
  • Statins and prostate cancer: Bias, precision medicine, or population health?
    Editorial

    Stopsack, K. H.
    European Urology (2021)

    Fulltext@MSK | Save
  • Intentional segmentectomy for clinical T1 N0 non-small cell lung cancer: Survival differs by segment
    Journal Article

    Jones, G. D.; Caso, R.; Choe, G.; Tan, K. S.; Connolly, J. G.; Dycoco, J.; Molena, D.; Park, B. J.; Huang, J.; Adusumilli, P. S.; more...
    Annals of Thoracic Surgery (2021)

    Fulltext@MSK | Save
  • Interpreting the RAPIDO trial: Factors to consider
    Correspondence

    Yuval, J. B.; Patil, S.; Garcia-Aguilar, J.
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • Oncologic outcomes after localized prostate cancer treatment: Associations with pretreatment prostate magnetic resonance imaging findings
    Journal Article

    Wibmer, A. G.; Chaim, J.; Lakhman, Y.; Lefkowitz, R. A.; Nincevic, J.; Nikolovski, I.; Sala, E.; Gonen, M.; Carlsson, S. V.; Fine, S. W.; more...
    Journal of Urology (2021)

    Fulltext@MSK | Save
  • Hepatocellular carcinoma in patients with no identifiable risk factors
    Journal Article

    McIntyre, C. A.; Chou, J. F.; Gonen, M.; Shia, J.; Gambarin-Gelwan, M.; Balachandran, V. P.; Kingham, T. P.; Allen, P. J.; Drebin, J. A.; Jarnagin, W. R.; more...
    HPB (2021)

    Fulltext@MSK | Save
  • Reply to Johann S. de Bono, Maha Hussain, and Jinyu Kang's letter to the editor re: Konrad H. Stopsack. Efficacy of PARP inhibition in metastatic castration-resistant prostate cancer is very different with non-BRCA DNA repair alterations: Reconstructing prespecified endpoints for cohort B from the phase 3 PROfound trial of olaparib. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.09.024
    Correspondence

    Stopsack, K. H.
    European Urology (2021)

    Fulltext@MSK | Save